Detalles de la búsqueda
1.
SAKK 19/17: safety analysis of first-line durvalumab in patients with PD-L1 positive, advanced nonsmall cell lung cancer and a performance status of 2.
Cancer Immunol Immunother
; 70(5): 1255-1262, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-33130956
2.
Adherence to ESMO clinical recommendations for prophylaxis of chemotherapy-induced nausea and vomiting.
Support Care Cancer
; 20(1): 141-7, 2012 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-21234609
3.
Reply to: adherence to recommendation for chemotherapy-induced nausea and vomiting prophylaxis: the proposal of a score.
Support Care Cancer
; 21(1): 7, 2013 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-23142923
Resultados
1 -
3
de 3
1
Próxima >
>>